Increase in Guillain-Barré Syndrome Following AstraZeneca COVID-19 Vaccine - SciTechDaily

A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barré syndrome, has been identified by University College London scientists, as part of an analysis of Unite…

ByUniversity College LondonJune 28, 2022 Guillain-Barré syndrome. Credit: UCL A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious … [+4936 chars]

full article...